Daily sedation interruption & RASS-targeted sedation
Sedation · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A sedation strategy that uses a validated scale (the Richmond Agitation-Sedation Scale) to target light sedation, with daily sedation interruption and spontaneous breathing trials, to shorten ventilation and ICU stay.
Red flags
- Deep sedation (with or without neuromuscular blockade) still required in severe ARDS, raised ICP, status epilepticus or severe dyssynchrony — defer the sedation hold
- Agitation causing self-extubation or line removal (under-sedation)
Assessment
Investigations
- RASS score and CAM-ICU delirium screen
- Readiness-to-wean / spontaneous-breathing-trial parameters
Management
- Set a target RASS (usually 0 to -2) unless deep sedation is clinically required
- Treat pain first — analgesia-based sedation
- Perform a daily sedation hold / awakening trial, paired with a spontaneous breathing trial where safe
- Screen for delirium (CAM-ICU) and minimise benzodiazepines
- Mobilise early once awake and stable
Drugs & doses
Analgesia-first approach; propofol or dexmedetomidine preferred over benzodiazepines
Disposition
Protocolised ICU sedation with daily review of depth and weaning readiness.
Complications & pitfalls
- Over-sedation: prolonged ventilation, delirium, VAP, weakness, hypotension
- Under-sedation: agitation, self-extubation, ventilator dyssynchrony
Exam pearls
- Analgesia first, then the lightest sedation that is safe
- Pair the daily awakening with a spontaneous breathing trial
- Avoid benzodiazepines where possible — they drive delirium
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.